Thank you to all who submitted poster abstracts

Poster submission is closed. We encouraged scholars, researchers and industry stake-holders to submit poster abstracts for Metabesity 2019. Suggested topic areas are listed on this page.

​Please note that all confirmed poster presenters are required to register for the conference.

Information for poster Presenters

Poster Size
Poster boards are 6’ (feet) wide x 4’ (feet) high and are hook-and-loop and push-pin friendly.​

Poster Design
Below is a link to a video by Mike Morrison, a researcher who developed a poster design that is highly efficient at conveying the main conclusion from his study while still providing more detail for those who want it. The added benefit is that he is able to create a poster faster with this design than with an older format.

How to create a better research poster in less time (YouTube)
Better Research Poster Templates (.pptx and .png)
Mike Morrison

Example of a poster created with the new format:
Hyun Gyu Suh on Hydration Assessment

Example of a QR code generator:
https://www.qr-code-generator.com

Poster Printing
Below is a link for a printer that specializes in scientific posters and has an office in Washington, DC. You are also welcome to search for other printers.
scientificposterprinting.com

Poster Presentation
Printed posters will be available for viewing both days of the conference. Posters will be located in Boardroom at the Carnegie Institution for Science.
 
Setup Time: Tuesday, October 15, 2019, 7:30-8:30 AM

Poster Sessions (please be present at your poster):
Tuesday, October 15, 2019, 1:30-2:00 PM
Wednesday, October 16, 2019, 1:20-1:50 PM

​Posters must be removed by 6:00 PM on Wednesday, October 16, 2019.

Abstract Topic Areas

 Aging and Sarcopenia 

• Metabolic pathways and signaling
• Genomic and other means of high risk identification
• Validation of targets
• Animal model studies
• Evaluation of candidate interventions (nutritional, pharmacologic, life style) 
• Methods to interpret translatability of animal results
• Clinical efficacy endpoints validation (functional and person-reported instruments) 
• Proposed clinical design approaches
• New clinical study results
• Epidemiology analysis and studies 
• Comparison of major regulatory positions
• Specific bioethical considerations

Cancer

• Metabolic pathways and signaling
• Validated targets
• Animal study results
• Utility of animal models
• Evaluation of current and novel candidate interventions (nutritional, pharmacologic, life style)
• Genomic and other means of high risk identification
• Clinical studies
• Epidemiology analysis and studies 
• Meta-analyses of clinical studies and lessons learned from chemoprevention trials

Diabetes

• Metabolic pathway and signaling
• Islet biology (embryogenesis and homeostasis of islet mass and function)
• Immunity (pathogenesis and interventions)
• Validation of metabolic, inflammatory, and immunologic targets
• Animal model studies
• Methods to enhance translation of animal results
• Genomic and other means of high risk identification
• Clinical efficacy endpoints validation 
• Proposed clinical design approaches
• Clinical studies
• New analyses of reported clinical trials 
• Lessons learned from T1D and T2D prevention trials
• Comparison of major regulatory positions

Neurodegeneration

• Metabolic pathway and signaling
• Validation of targets
• Animal model studies
• Methods to enhance translation of animal results
• Clinical efficacy endpoints validation 
• Proposed clinical design approaches
• Clinical studies
• Comparison of major regulatory positions​

General Approaches and Tools for Metabesity

• Metabesity pathways and signaling (choke points and pleotropic agents that leverage 2 or more major clinical outcomes)
• Animal model development
• Biomarkers and imaging
• Efficacy endpoints—functional, quality life survival, person-reported
• Microbiome (mechanisms, characterization, interventions)
• General issues related to repurposing approved therapies
• Acquiring and managing big data
• Biostatistical methods
• Cost-effectiveness approaches relevant to payors and policy makers
• Regulatory approaches
• Apps and other engagement and tracking tools
• Education 
• Econometrics
• Bioethics 
• Public policy and public health approaches